Trial Profile
An Exploratory, Randomized, Placebo-Controlled, Double-Blind, Crossover Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors Avalo Therapeutics; Cerecor
- 10 Apr 2014 New trial record